Literature DB >> 15078972

A human immunodeficiency virus type 1-infected individual with low viral load harbors a virus variant that exhibits an in vitro RNA dimerization defect.

Hendrik Huthoff1, Atze T Das, Monique Vink, Bep Klaver, Fokla Zorgdrager, Marion Cornelissen, Ben Berkhout.   

Abstract

We investigated the in vitro RNA dimerization properties of the untranslated leader RNA derived from human immunodeficiency virus type 1 variants circulating in an individual with a low viral load and slow disease progression. The leader sequences of these viruses contain highly unusual polymorphisms within the dimerization initiation site (DIS): an insert that abolishes dimerization and a compensatory substitution. The dimerization of leader RNA from late stages of infection is further improved by additional mutations outside the DIS motif that facilitate a secondary structure switch from a dimerization-incompetent to a dimerization-competent RNA conformation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15078972      PMCID: PMC387700          DOI: 10.1128/jvi.78.9.4907-4913.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Dimerization of HIV-1 genomic RNA of subtypes A and B: RNA loop structure and magnesium binding.

Authors:  F Jossinet; J C Paillart; E Westhof; T Hermann; E Skripkin; J S Lodmell; C Ehresmann; B Ehresmann; R Marquet
Journal:  RNA       Date:  1999-09       Impact factor: 4.942

Review 2.  Structure and function of the human immunodeficiency virus leader RNA.

Authors:  B Berkhout
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1996

3.  A kissing complex together with a stable dimer is involved in the HIV-1Lai RNA dimerization process in vitro.

Authors:  D Muriaux; P Fossé; J Paoletti
Journal:  Biochemistry       Date:  1996-04-16       Impact factor: 3.162

4.  Requirements for kissing-loop-mediated dimerization of human immunodeficiency virus RNA.

Authors:  J L Clever; M L Wong; T G Parslow
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

Review 5.  Closing in on human immunodeficiency virus-1.

Authors:  J W Mellors
Journal:  Nat Med       Date:  1996-03       Impact factor: 53.440

6.  Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection.

Authors:  F Kirchhoff; T C Greenough; D B Brettler; J L Sullivan; R C Desrosiers
Journal:  N Engl J Med       Date:  1995-01-26       Impact factor: 91.245

7.  A loop-loop "kissing" complex is the essential part of the dimer linkage of genomic HIV-1 RNA.

Authors:  J C Paillart; E Skripkin; B Ehresmann; C Ehresmann; R Marquet
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

8.  Prognosis in HIV-1 infection predicted by the quantity of virus in plasma.

Authors:  J W Mellors; C R Rinaldo; P Gupta; R M White; J A Todd; L A Kingsley
Journal:  Science       Date:  1996-05-24       Impact factor: 47.728

9.  Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual.

Authors:  A K Iversen; E G Shpaer; A G Rodrigo; M S Hirsch; B D Walker; H W Sheppard; T C Merigan; J I Mullins
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

10.  Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients.

Authors:  N J Deacon; A Tsykin; A Solomon; K Smith; M Ludford-Menting; D J Hooker; D A McPhee; A L Greenway; A Ellett; C Chatfield; V A Lawson; S Crowe; A Maerz; S Sonza; J Learmont; J S Sullivan; A Cunningham; D Dwyer; D Dowton; J Mills
Journal:  Science       Date:  1995-11-10       Impact factor: 47.728

View more
  10 in total

1.  Fifteen to twenty percent of HIV substitution mutations are associated with recombination.

Authors:  Timothy E Schlub; Andrew J Grimm; Redmond P Smyth; Deborah Cromer; Abha Chopra; Simon Mallal; Vanessa Venturi; Caryll Waugh; Johnson Mak; Miles P Davenport
Journal:  J Virol       Date:  2014-01-22       Impact factor: 5.103

2.  Delineation of the preferences and requirements of the human immunodeficiency virus type 1 dimerization initiation signal by using an in vivo cell-based selection approach.

Authors:  Islam T M Hussein; Na Ni; Andrea Galli; Jianbo Chen; Michael D Moore; Wei-Shau Hu
Journal:  J Virol       Date:  2010-04-21       Impact factor: 5.103

Review 3.  Extensive purifying selection acting on synonymous sites in HIV-1 Group M sequences.

Authors:  Nobubelo K Ngandu; Konrad Scheffler; Penny Moore; Zenda Woodman; Darren Martin; Cathal Seoighe
Journal:  Virol J       Date:  2008-12-23       Impact factor: 4.099

4.  Mutations in matrix and SP1 repair the packaging specificity of a Human Immunodeficiency Virus Type 1 mutant by reducing the association of Gag with spliced viral RNA.

Authors:  Natalia Ristic; Mario P S Chin
Journal:  Retrovirology       Date:  2010-09-08       Impact factor: 4.602

5.  Optimal packaging of FIV genomic RNA depends upon a conserved long-range interaction and a palindromic sequence within gag.

Authors:  Tahir A Rizvi; Julia C Kenyon; Jahabar Ali; Suriya J Aktar; Pretty S Phillip; Akela Ghazawi; Farah Mustafa; Andrew M L Lever
Journal:  J Mol Biol       Date:  2010-08-21       Impact factor: 5.469

6.  Primary T-lymphocytes rescue the replication of HIV-1 DIS RNA mutants in part by facilitating reverse transcription.

Authors:  Kate L Jones; Secondo Sonza; Johnson Mak
Journal:  Nucleic Acids Res       Date:  2008-01-23       Impact factor: 16.971

7.  Identification of a cluster of HIV-1 controllers infected with low replicating viruses.

Authors:  Concepción Casado; Maria Pernas; Virginia Sandonis; Tamara Alvaro-Cifuentes; Isabel Olivares; Rosa Fuentes; Lorena Martínez-Prats; Eulalia Grau; Lidia Ruiz; Rafael Delgado; Carmen Rodríguez; Jorge del Romero; Cecilio López-Galíndez
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

Review 8.  The retroviral RNA dimer linkage: different structures may reflect different roles.

Authors:  Jane Greatorex
Journal:  Retrovirology       Date:  2004-08-18       Impact factor: 4.602

Review 9.  Translational HIV-1 research: from routine diagnostics to new virology insights in Amsterdam, the Netherlands during 1983-2013.

Authors:  Antoinette C van der Kuyl; Margreet Bakker; Suzanne Jurriaans; Nicole K T Back; Alexander O Pasternak; Marion Cornelissen; Ben Berkhout
Journal:  Retrovirology       Date:  2013-08-28       Impact factor: 4.602

Review 10.  What do we measure when we measure cell-associated HIV RNA.

Authors:  Alexander O Pasternak; Ben Berkhout
Journal:  Retrovirology       Date:  2018-01-29       Impact factor: 4.602

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.